This chemical is primarily utilized in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting the central nervous system, including potential treatments for neurological disorders and pain management. Its trifluoroethyl group enhances the metabolic stability and bioavailability of the resulting molecules, making it valuable in medicinal chemistry. Additionally, it is employed in research settings for the development of novel compounds with potential therapeutic applications, particularly in areas requiring modulation of receptor activity or enzyme inhibition.